About RBC
BUILDING HEALTHCARE OPPORTUNITIES.
Running Bricks Corporate (Pty) Ltd, trading as RBC Pharmaceuticals (Pty) Ltd, is a South African healthcare company established in 2017.
Our model
RBC has developed capabilities across pharmaceuticals, complementary medicines, medical devices, diagnostics, veterinary healthcare, regulatory affairs, product supply and healthcare commercialisation.
Today, RBC operates through an integrated model that brings together:
- Regulatory Expertise
- Market Access
- Commercialisation
- Supply
Our objective is to connect quality healthcare products, manufacturers and strategic partners with appropriate opportunities within the South African healthcare market.
Our journey
FROM FOUNDATION TO HEALTHCARE GROWTH.
- 2017
RBC Established
Running Bricks Corporate (Pty) Ltd, trading as RBC Pharmaceuticals, established in South Africa.
- 2019
Medical Devices
Expanded into medical devices and obtained the applicable SAHPRA Medical Device Licence.
- 2020
Regulatory & Consulting
Developed regulatory affairs, compliance and healthcare consulting capabilities.
- 2021
Pharmaceutical & Healthcare Development
Expanded pharmaceutical, medical-device and healthcare product registration and supply capabilities.
- 2022
Pharmaceutical Market Development
Expanded pharmaceutical market activities and strengthened applicable regulatory, professional and healthcare-sector capabilities.
- 2023
Complementary Medicines & Healthcare Solutions
Expanded capabilities into complementary medicines, medical devices, healthcare products and commercialisation.
- 2024
Market Expansion
Expanded commercial activities across public and private healthcare sectors in South Africa and global opportunities.
- 2025
Commercialisation & Market Access
Strengthened RBC's integrated healthcare commercialisation and market-access platform.
- 2026
Institutional Market Access
Achieved ISO 13485 certification and expanded participation in institutional and National Department of Health supply opportunities.
Quality & compliance
QUALITY IS OUR FOUNDATION.
RBC is committed to quality, compliance, documentation, traceability and responsible healthcare-product supply.
Licensed
SAHPRA
South African Health Products Regulatory Authority.
Licensed
DoH
Department of Health.
Certified
SAPC
South African Pharmacy Council.
Certified
ISO 13485
For RBC's medical devices quality management system.
Our quality principles include:
- Patient Safety
- Product Integrity
- Regulatory Compliance
- Supplier Qualification
- Documentation
- Traceability
- Complaint Management
- Recall Readiness
- Continuous Improvement
RBC is ISO 13485 certified for its medical devices quality management system.
Global partners & industry network
STRATEGIC INDUSTRY NETWORK.
RBC works with a growing network of pharmaceutical manufacturers, healthcare companies, medical-device organisations, diagnostic companies and other industry stakeholders.
Our international engagement supports knowledge exchange, strategic partnerships, product identification and opportunities for South African market development.
CONNECTING WITH THE GLOBAL HEALTHCARE INDUSTRY.
RBC actively engages with international and national pharmaceutical and healthcare industry platforms.
International engagements
- CPHI
- Barcelona 2023 · Milan 2024 · Frankfurt 2025 · Milan 2026
- IPHEX India
- 2022 · 2023 · 2024 · 2025 · 2026
- CPHI & PMEC China
- 2025 · 2026
- WHX Dubai
- 2026
- KOTRA — Korea Trade-Investment Promotion Agency
- 2023
South African industry engagement
- WHX Johannesburg
- WHX Cape Town
- Pharmhealth Expos
- The Pharmacy Show
- SAPHEX
RBC continues to engage with professional and industry networks that support knowledge sharing, collaboration, partnerships and continued development within the pharmaceutical and healthcare sectors.